| Authors: |
Readhead B; ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ, 85281, USA. ben.readhead@asu.edu., Klang E; Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel., Gisladottir U; Department of Biomedical Informatics, Columbia University, New York, NY, USA., Vandromme M; Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Li L; Sema4, Stamford, CT, USA., Quiroz YT; Departments of Psychiatry and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Arboleda-Velasquez JF; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA., Dudley JT; ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ, 85281, USA.; Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Tatonetti NP; Department of Biomedical Informatics, Columbia University, New York, NY, USA.; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Glicksberg BS; Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Reiman EM; ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ, 85281, USA.; Banner Alzheimer's Institute, Phoenix, AZ, 85006, USA. |